MP Healthcare Venture Management
Signal active
Investment Firm
Overview
MPH is the venture capital arm of Mitsubishi Tanabe Pharma Corporation (MTPC). MPH invests in innovative companies developing novel therapeutics, platform technologies, and vaccines.
Highlights
Founded
2006
Industry
Venture Capital
Employees
1-10
Investment
43
Lead Investment
4
Exits
10
Stages
Early Stage Venture, Seed, Late Stage Venture
Investor Type
Corporate Venture Capital
Location
Boston, Massachusetts, United States, North America
Contact Information
Social
Profile Resume
MP Healthcare Venture Management, established in 2006 and headquartered in United States, North America., specializes in Early Stage Venture, Seed, Late Stage Venture investments across Biotechnology, Health Care, Therapeutics, Venture Capital, Finance, Financial Services, Impact Investing, Life Science, Innovation Management, Pharmaceutical. The organization boasts a portfolio of 41 investments, with an average round size of $23.9M and 10 successful exits. Their recent investments include Intradigm Corporation, Frazier Healthcare Partners, Roche Venture Fund, Novartis Venture Fund, Alta Partners. The highest investment round they participated in was $104.1B. Among their most notable exits are Intradigm Corporation and Frazier Healthcare Partners. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
MP Healthcare Venture Management has made 43 investments. Their most recent investment was on Aug 01, 2024, when Libero Thera raised $1.3M.
investments
43
Diversity investments
3
Lead investments
4
Number of exits
10
Investments
43
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| May 22, 2023 | - | - | 7.5M |
| Apr 18, 2024 | Outrun TX | Biotechnology | 10.0M |
| Jul 17, 2024 | Draupnir Bio | Biotechnology | 13.2M |
| Aug 01, 2024 | Libero Thera | Biotechnology | 1.3M |
Exits
10
Funding Timeline
Funding rounds
43
Investors
0
Funds
0
Funding Rounds
43
MP Healthcare Venture Management has raised 43 rounds. Their latest funding was raised on Aug 01, 2024 from a Venture Round - Libero Thera round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| May 22, 2023 | Seed Round - PharmEnable | - | 7.5M | - |
| Apr 18, 2024 | Seed Round - Outrun TX | - | 10.0M | - |
| Jul 17, 2024 | Seed Round - Draupnir Bio | - | 13.2M | - |
| Aug 01, 2024 | Venture Round - Libero Thera | - | 1.3M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
Funding Round
Aug 01, 2024
Libero Thera raised $1340382 on 2024-08-01 in Venture Round
Funding Round
Jul 17, 2024
Draupnir Bio raised $13198813 on 2024-07-17 in Seed Round
Funding Round
Apr 18, 2024
Outrun TX raised $10000000 on 2024-04-18 in Seed Round
Funding Round
May 22, 2023
PharmEnable raised $7460367 on 2023-05-22 in Seed Round
Funding Round
Mar 09, 2023
QurAlis raised $88000000 on 2023-03-09 in Series B